Research using animal models has helped elucidate the neural mechanisms of angina pectoris, sensitization of cardiac nociceptive stimuli, and neuromodulation of cardiac pain and cardiovascular function. Findings over the last 2 decades include evidence of convergence of visceral-somatic input to spinothalamic cells and a major role for the vagus nerve in spinal cord processing. Stress-related glucocorticoids may manipulate amygdala function, inducing hypersensitivity to nociceptive input from the heart via central sensitization of upper thoracic spinal neuronal activity. Spinal cord stimulation may have therapeutic effects, although the underlying mechanism is unclear.
T
he cardinal symptoms of angina pectorischest pain and pain that may radiate to either arm or the neck and jaw-are well recognized. The visceral characteristics of anginal pain are also familiar; for example, referral to somatic structures, pain that is diffuse and poorly localized, skin and deep tissue tenderness, enhanced autonomic refl exes such as sweating and vasomotor symptoms, and muscular rigidity.
The neurologic mechanisms that explain the manifestations of angina pectoris are less well clarifi ed, and are targets of active research. Our research into the neuromodulation of cardiovascular function over the last 2 decades has produced results that may have clinical implications and others that have raised new questions. This article summarizes some of our key fi ndings from studies of neural mechanisms of angina pectoris, central sensitization of cardiac nociceptive stimuli, and the neuromodulation of cardiac pain, with a focus on processing in the spinal cord.
NEURAL MECHANISMS OF ANGINA PECTORIS
Cells of the spinothalamic tract form a sensory pathway that transmits afferent information to the thalamus. 1 One of our research objectives was to examine how these cells process information when the heart is exposed to noxious stimuli.
Thoracic spinal processing
The animal model for our early studies was an anesthetized primate. The afferent nerves were activated in one of two ways: either the coronary artery was occluded or bradykinin and algesic chemicals were injected into the pericardial sac or left atrial appendage. Recorded activity was then made from the spinothalamic tract cells in the T1-T5 and C5-C6 segments. 1 We found convergence of visceral and somatic input, generally to the chest and upper arm. The fi nding was consistent with the observation that pain from angina commonly occurs in proximal somatic fi elds. No visceral input was evident in cells in C7-C8, where the somatic effects are primarily distal-to the hand, for example.
Upper cervical processing
It is known that some patients experience angina pectoris as neck and jaw pain. The dental literature has shown that what is initially considered to be a toothache occasionally turns out to be angina and coronary artery disease. 2 Clinical literature from the late 1940s observed that despite the use of sympathectomy to relieve angina pectoris, neck and jaw pain continued or developed. 3, 4 This pain was attributed to transmission of nociceptive information in vagal afferent fi bers, commonly thought to transmit innocuous cardiac sensory information.
When we recorded activity from spinothalamic tract cells in the C1-C2 region to observe the effect
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of cardiac nociceptive stimulation, we demonstrated a major role for the vagus nerve. 1 Injection of saline into the heart had no effect in the C1-C2 region, but injection of algesic chemicals into the pericardial sac caused signifi cant activity that disappeared after transection of the vagus nerve. This fi nding suggested that vagal afferent fi bers ascend into the nucleus tractus solitarius of the medulla and either directly or indirectly modulate the C1-C2 neurons, which also receive converging somatic information from the neck and jaw region.
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CENTRAL SENSITIZATION OF CARDIAC NOCICEPTIVE STIMULI
Clinical studies suggest that anxiety and depression are prevalent in patients suffering from chest pain with and without underlying cardiac disease. 6 Anxiety and/or stress increases circulating levels of corticosteroids, which can act on the glucocorticoid receptors in the amygdala, particularly in the central area. 7 The amygdala plays a pivotal role in transforming chronic stressful stimuli into behavioral, visceral, and autonomic responses. 8 Previous studies have shown that corticosteroids upregulate expressions of corticotropin-releasing factor in the central nucleus of the amygdala and increase indices of anxiety. 7, 9 They are also associated with hypersensitivity in visceromotor responses to colorectal distention 10 and sensitize lumbosacral spinal neurons to colorectal and urinary bladder distention. 11, 12 We therefore hypothesized that glucocorticoids manipulate amygdala function, inducing hypersensitivity to nociceptive input from the heart through the modulation of upper thoracic spinal neuronal activity.
To examine the impact of stress on the nervous system when the heart is exposed to noxious stimuli, we assessed the effect of chronic activation of the amygdala on the T3-T4 spinal neurons and on C1-C2 propriospinal neurons. Fisher 344 rats were selected for this study because of their relatively low level of anxiety-related behavior. 9 Micropellets of crystalline corticosterone or cholesterol (30 μg, used as a control) were implanted in the central nucleus of the amygdala. After 7 days, the corticosterone-implanted, but not the cholesterol-implanted, animals displayed high-anxiety behavior, as determined with an elevated plus maze. 7 The responses of T3-T4 spinal neurons to intrapericardial injections of the algesic chemical bradykinin were compared in the corticosterone-and cholesterolimplanted rats. Compared with cholesterol-implanted animals, the duration of activity in response to the noxious cardiac stimulus was signifi cantly longer in the corticosterone-implanted rats; in addition, activity shifted from the short-lasting (the response lasts only as long as the stimulus is applied) to long-lasting excitatory (the response lasts well beyond the period the stimulus is applied) neurons. Long-lasting excitatory neuronal activity is associated with intense pain and hypersensitivity, while short-lasting neurons are associated with a more acute response. The number of neurons with large fi eld sizes in the corticosteroneimplanted animals also increased, which is another indication of sensitization.
To study the role of the propriospinal pathway from C1-C2 segments in transmitting information from the amygdala to the thoracic spinal cord, we stimulated the central nucleus of the amygdala, which created a burst activity in T2-T4 spinal neurons that ended when the stimulus was removed. We then exposed the C1-C2 and C5-C6 spinal cord segments to ibotenic acid, which disrupts cell function but does not affect axons, and repeated the amygdala stimulation. Overall, the responses of 65% of the T2-T4 cells tested by amygdala stimulation were eliminated after C1-C2 cell disruption, but none of the neuronal responses to amygdala stimulation were eliminated after ibotenic acid was applied to the C5-C6 segments. The results suggest that C1-C2 plays a role in transmitting information from the amygdala to the T3-T4 neurons, and that there is a small direct pathway between the two areas (Figure 1 ).
NEUROMODULATION OF CEREBROVASCULATURE AND CARDIAC PAIN
Neuromodulation of cerebral blood fl ow
Spinal cord stimulation is used to treat several cerebrovascular disorders, including cerebral ischemia, focal cerebral ischemia, stroke, postapoplectic spastic hemiplegia, and prolonged coma (see Yang et al 13 for citations that address these pathologies). There is no clear explanation for its therapeutic effect; mechanisms being investigated include changes in cerebral blood fl ow and processing of nociceptive information.
To assess the effect of spinal cord stimulation on cerebral blood fl ow, we exposed the C1-C2 area of an anesthetized rat, stimulated the area with a ball electrode, and used laser Doppler fl ow probes to measure the blood fl ow on the surface of the cortex bilaterally. 13 The stimulus parameters were 30%, 60%, and 90% of motor threshold; the threshold was determined by gradually increasing the intensity of spinal
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cord stimulation until the neck muscles contracted. Blood fl ow increased on both sides with increasing stimulation intensities. 13 Other studies have evaluated cerebral blood fl ow but did not measure change in cerebrovascular resistance. We observed that spinal cord stimulationparticularly at 60% and 90% of motor thresholdincreased blood fl ow and reduced resistance to spinal cord stimulation on the dorsal columns at C1, both ipsilaterally and contralaterally.
In other tests, cerebral blood fl ow and vascular resistance to spinal cord stimulation were not changed after transection of the spinal cord at the C6-C7 segments. These results suggested that information was not being transmitted to the sympathetic nervous system via the thoracic spinal cord. We applied ibotenic acid to C1-C2 to assess whether the underlying stimulated neurons affected cerebral blood fl ow; there was no signifi cant change. On the other hand, a small cut in the dorsal column rostral to the stimulation site caused signifi cantly reduced cerebral blood fl ow and vascular resistance, indicating that the dorsal columns function in an ascending manner to produce the vasodilation in the cerebral cortex. 13 Capsaicin-sensitive sensory nerves, which contain transient receptor potential vanilloid-1 (TRPV1) receptors, may have a role in spinal cord stimulationinduced vasodilation. TRPV1 receptors are nonselective cation channels activated by capsaicin, heat, and hydrogen ions.
14 Activation, which causes an infl ux of cations and release of calcitonin gene-related peptide (CGRP) and substance P, is related to the pathogenesis of infl ammation and hypertension. To examine the potential role played by capsaicin-sensitive sensory nerves, we administered resiniferatoxin (RTX), an ultrapotent capsaicin agonist; RTX specifi cally targets and desensitizes TRPV1-containing sensory fi bers. 13, 15 Administration either intravenously or by direct application to the spinal cord results in a 15-to 20-minute period of sensitization followed by several hours of desensitization; if exposure lasts for several days, the nerves are destroyed.
Intrathecal administration of RTX to the spinal cord resulted in no signifi cant change in cerebral blood fl ow. However, intravenous administration resulted in signifi cantly decreased cerebral blood fl ow and decreased resistance, suggesting a role for TRPV1 receptors in cerebral blood fl ow. 13 There may be a connection between spinal cord stimulation at C1 and vasodilation of the cortex. The literature suggests that spinal cord stimulation activates the dorsal column nuclei 16 ; we found evidence of this in our laboratory when we recorded activity from cells in the cuneate and gracilus nuclei after spinal cord stimulation. There is also a possible pathway between the dorsal column, the rostral ventrolateral medulla, and the sphenopalatine ganglion that infl uences vasodilation. [17] [18] [19] [20] Although not yet clearly defi ned, evidence suggests a connection between spinal cord stimulation and transmission of this information through the dorsal columns to infl uence vasodilation. [17] [18] [19] [20] Neuromodulation of thoracic spinal processing of cardiac nociceptive information Stimulating the dorsal columns activates the large afferent fi bers, which in turn activate neuronal mechanisms in the spinal cord gray matter. These mecha- 
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nisms may be partly attributed to "gate control," in which large afferent fi bers can decrease the amount of information coming from the nociceptive afferent nerves to reduce the nociceptive sensation. 15, 21, 22 González-Darder et al 23 considered this mechanism in a study of 12 patients with unstable angina (Table  1) . Upper cervical spinal cord stimulation resulted in a decreased number of anginal episodes per week and an improved rate-pressure product (heart rate × systolic blood pressure). Their fi ndings suggest that stimulating the upper cervical region could achieve effects similar to those seen after stimulating the spinal cord at T2. Using a rat model to assess the effects of spinal stimulation, we recorded T3 activity during dorsal column stimulation of either C8-T1 or C1-C2 segments. Activity was almost completely suppressed with C1-C2 stimulation during bradykinin injection into the pericardial sac. The results suggest that spinal cord stimulation suppresses the processing of nociceptive information. 24 Stimulating the spinal cord at C8-T1 also suppresses the effect of bradykinin. One possible mechanism for this effect is that spinal cord stimulation activates large afferent fi bers; GABAergic connections in the superfi cial dorsal horn may suppress the processing of information in the spinothalamic tract neurons.
22,25
SUMMARY
Our investigations have generated information about afferent input to the spinothalamic tract cells, the effects of glucocorticoids on amygdala function, and possible therapeutic mechanisms of spinal cord stimulation.
We have demonstrated convergence of viscerosomatic input in spinothalamic cells. There is virtually no viscerocardiac input at the C7-C8 region, but there is input at C5-C6. Vagal afferent activity is the major source of input at the C1-C2 region; vagal stimulation also affects propriospinal neurons in this region. Vagal nerve stimulation may have a major role in processing in the upper cervical spinal cord and may change the balance of processing in the supraspinal nuclei.
Glucocorticoids manipulate amygdala function by inducing hypersensitivity to nociceptive input from the heart through central sensitization of upper thoracic spinal neuronal activity. Descending information from the amygdala depends, in part, on the C1-C2 propriospinal pathway.
Spinal cord stimulation at C1-C2 or C8-T1 can activate inner neuronal mechanisms that may involve GABA, modulating the wide dynamic range of neurons that are part of the spinothalamic tract. 23 Heart rate-systolic blood Angina pressure product attacks/wk (beats/min × mm Hg)/1,000
Pre-SCS 30.9 ± 14.5 9.6 ± 1.9 Post-SCS 9.6 ± 8.2 14.1 ± 3.4 P value < .01 < .01
